Variant report
Variant | nsv1024194 |
---|---|
Chromosome Location | chr5:29069765-29082654 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:107)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr5:29070987-29071060 | K562 | blood: | n/a | n/a |
2 | BRCA1 | chr5:29077488-29077830 | Hela-S3 | cervix: | n/a | n/a |
3 | CCNT2 | chr5:29079757-29080002 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr5:29072750-29072805 | HepG2 | liver: | n/a | chr5:29072772-29072783 |
5 | CEBPB | chr5:29077957-29078214 | A549 | lung: | n/a | n/a |
6 | CEBPB | chr5:29077432-29078233 | Hela-S3 | cervix: | n/a | n/a |
7 | CHD2 | chr5:29077610-29077959 | Hela-S3 | cervix: | n/a | n/a |
8 | CHD2 | chr5:29079997-29080028 | Hela-S3 | cervix: | n/a | n/a |
9 | CTCF | chr5:29079972-29080131 | MCF-7 | breast: | n/a | n/a |
10 | CTCF | chr5:29079960-29080110 | HepG2 | liver: | n/a | n/a |
11 | CTCF | chr5:29080011-29080049 | GM13976 | blood: | n/a | n/a |
12 | CTCF | chr5:29079940-29080090 | GM12874 | blood: | n/a | n/a |
13 | CTCF | chr5:29079960-29080110 | GM12866 | blood: | n/a | n/a |
14 | CTCF | chr5:29079895-29080131 | HepG2 | liver: | n/a | n/a |
15 | CTCF | chr5:29079940-29080090 | HRPEpiC | eye: | n/a | n/a |
16 | CTCF | chr5:29080000-29080150 | A549 | lung: | n/a | n/a |
17 | CTCF | chr5:29080020-29080170 | HBMEC | blood vessel: | n/a | n/a |
18 | CTCF | chr5:29079960-29080110 | MCF-7 | breast: | n/a | n/a |
19 | CTCF | chr5:29079988-29080113 | A549 | lung: | n/a | n/a |
20 | CTCF | chr5:29080000-29080150 | RPTEC | kidney: | n/a | n/a |
21 | CTCF | chr5:29079960-29080110 | BE2_C | brain: | n/a | n/a |
22 | CTCF | chr5:29080000-29080150 | BE2_C | brain: | n/a | n/a |
23 | CTCF | chr5:29079949-29080141 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | CTCF | chr5:29079968-29080103 | LNCaP | prostate: | n/a | n/a |
25 | CTCF | chr5:29079979-29080122 | Gliobla | brain: | n/a | n/a |
26 | CTCF | chr5:29079877-29080217 | GM12878 | blood: | n/a | n/a |
27 | CTCF | chr5:29079880-29080030 | Hela-S3 | cervix: | n/a | n/a |
28 | CTCF | chr5:29079993-29080068 | NHEK | skin: | n/a | n/a |
29 | CTCF | chr5:29079940-29080090 | MCF-7 | breast: | n/a | n/a |
30 | CTCF | chr5:29080000-29080150 | GM12871 | blood: | n/a | n/a |
31 | CTCF | chr5:29079960-29080110 | WERI-Rb-1 | eye: | n/a | n/a |
32 | CTCF | chr5:29079990-29080039 | Kidney_OC | kidney: | n/a | n/a |
33 | CTCF | chr5:29080000-29080150 | NB4 | blood: | n/a | n/a |
34 | CTCF | chr5:29079940-29080090 | SK-N-SH_RA | brain: | n/a | n/a |
35 | CTCF | chr5:29079960-29080110 | HEK293 | kidney: | n/a | n/a |
36 | CTCF | chr5:29079945-29080142 | MCF-7 | breast: | n/a | n/a |
37 | CTCF | chr5:29079779-29080257 | MCF-7 | breast: | n/a | n/a |
38 | CTCF | chr5:29079900-29080050 | HCPEpiC | choroid plexus: | n/a | n/a |
39 | CTCF | chr5:29079880-29080030 | HRPEpiC | eye: | n/a | n/a |
40 | CTCF | chr5:29079960-29080110 | GM12875 | blood: | n/a | n/a |
41 | CTCF | chr5:29079910-29080169 | MCF-7 | breast: | n/a | n/a |
42 | CTCF | chr5:29080000-29080150 | K562 | blood: | n/a | n/a |
43 | CTCF | chr5:29079951-29080141 | HepG2 | liver: | n/a | n/a |
44 | CTCF | chr5:29079962-29080076 | SK-N-SH_RA | brain: | n/a | n/a |
45 | CTCF | chr5:29079940-29080090 | WERI-Rb-1 | eye: | n/a | n/a |
46 | CTCF | chr5:29079825-29080198 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | CTCF | chr5:29079980-29080134 | GM12878 | blood: | n/a | n/a |
48 | CTCF | chr5:29079960-29080110 | RPTEC | kidney: | n/a | n/a |
49 | CTCF | chr5:29081691-29081727 | GM10266 | blood: | n/a | n/a |
50 | CTCF | chr5:29079874-29080217 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDH6-3 | chr5:29073007-29073330 | NR_109948 |
2 | lnc-CDH6-3 | chr5:29066381-29070363 | ENSG00000249322 |
3 | lnc-CDH6-3 | chr5:29066381-29070363 | NR_109948 |
4 | lnc-CDH6-3 | chr5:29073007-29073329 | ENSG00000249322 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000252601 | TF binding region |
FOXD1 | miRNA target sites |
CBFB | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528778714 | chr5:29069795-29069796 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs73747184 | chr5:29069819-29069820 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs544296774 | chr5:29069845-29069846 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs546941115 | chr5:29069854-29069855 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs568724365 | chr5:29069872-29069873 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs147514672 | chr5:29069901-29069902 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs527826714 | chr5:29069920-29069921 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs541114381 | chr5:29069943-29069944 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs557323061 | chr5:29069986-29069987 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs569416766 | chr5:29070006-29070007 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs539901854 | chr5:29070016-29070017 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs557987828 | chr5:29070034-29070035 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs160306 | chr5:29070094-29070095 | Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs57512264 | chr5:29070129-29070130 | Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs117120997 | chr5:29070156-29070157 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs181324605 | chr5:29070175-29070176 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs573874981 | chr5:29070182-29070183 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs6859756 | chr5:29070193-29070194 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs61341566 | chr5:29070203-29070204 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs552102365 | chr5:29070221-29070222 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs140042993 | chr5:29070293-29070294 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs530061269 | chr5:29070308-29070309 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs577320114 | chr5:29070310-29070311 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs62353939 | chr5:29070333-29070334 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs112656347 | chr5:29070334-29070335 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs145135703 | chr5:29070343-29070344 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs569068921 | chr5:29070364-29070365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142304192 | chr5:29070384-29070385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs72279064 | chr5:29070395-29070396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201818957 | chr5:29070396-29070397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143070676 | chr5:29070441-29070442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57098755 | chr5:29070444-29070445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs160305 | chr5:29070491-29070492 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs59114642 | chr5:29070504-29070505 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs184641792 | chr5:29070575-29070576 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs143950389 | chr5:29070582-29070583 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs550709612 | chr5:29070590-29070591 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs13359014 | chr5:29070593-29070594 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs539961476 | chr5:29070602-29070603 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs142054241 | chr5:29070626-29070627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76976404 | chr5:29070639-29070640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566948438 | chr5:29070641-29070642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533793289 | chr5:29070710-29070711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555527913 | chr5:29070719-29070720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs188656826 | chr5:29070792-29070793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115999511 | chr5:29073016-29073017 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs185630314 | chr5:29073044-29073045 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs554257251 | chr5:29073058-29073059 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs569776026 | chr5:29073064-29073065 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs537095773 | chr5:29073121-29073122 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Bipolar disorder | 19114987 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29068400-29070200 | Active TSS | Rectal Mucosa Donor 29 | rectum |
2 | chr5:29069600-29070800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr5:29077400-29078000 | Enhancers | A549 | lung |
4 | chr5:29077400-29078400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr5:29077400-29078400 | Enhancers | Hela-S3 | cervix |
6 | chr5:29077600-29078000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr5:29079200-29080000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |